Dorsey & Whitney Trust’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,500	Closed	-$213K	–	574
2022 Q3	$213K	Hold	9,500	–	–	0.02%	491
2022 Q2	$235K	Buy	9,500 +4,200	+79%	+$104K	0.02%	465
2022 Q1	$205K	Buy	+5,300	New	+$205K	0.02%	534